Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Caroline Sert"'
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundPuberty is delayed in untreated children and adolescents with severe primary IGF-1 deficiency (SPIGFD); to date, it has not been reported whether recombinant human insulin-like growth factor-1 mecasermin (rhIGF-1) treatment affects this. Pu
Externí odkaz:
https://doaj.org/article/d9b65a9af1114278a16597efcb706dce
Autor:
Regis Coutant, Jordi Bosch Muñoz, Cristina Patricia Dumitrescu, Dirk Schnabel, Caroline Sert, Valerie Perrot, Mehul Dattani
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ObjectiveThe International Cooperative Growth Study, NutropinAq® European Registry (iNCGS) (NCT00455728) monitored long-term safety and effectiveness of recombinant human growth hormone (rhGH; NutropinAq® [somatropin]) in paediatric growth disorder
Externí odkaz:
https://doaj.org/article/91aa7dbf31614290b139fa7bf831d2f1
Publikováno v:
European Journal of Endocrinology
Objective The European Increlex® Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex®) therapy in patients with severe primary IGF1 deficiency (SPIGFD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272ffe7a036cd72477204c1acdc44e6b
https://doi.org/10.1530/eje-20-0325
https://doi.org/10.1530/eje-20-0325
Publikováno v:
Pituitary
Purpose PRIMARYS (NCT00690898) was a 48-week, open-label, phase 3b study, evaluating treatment with the somatostatin receptor ligand lanreotide autogel (stable dose: 120 mg/28 days) in treatment-naïve patients with growth hormone (GH)-secreting pitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1e9cf66b6106f39468705ef8383f0b
https://doi.org/10.1007/s11102-019-01020-3
https://doi.org/10.1007/s11102-019-01020-3
Publikováno v:
Frontiers in endocrinology. 13
Puberty is delayed in untreated children and adolescents with severe primary IGF-1 deficiency (SPIGFD); to date, it has not been reported whether recombinant human insulin-like growth factor-1 mecasermin (rhIGF-1) treatment affects this. Pubertal gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::38db4765b7e10983ae7b471a14c64876
https://pubmed.ncbi.nlm.nih.gov/35250870
https://pubmed.ncbi.nlm.nih.gov/35250870
Autor:
Mehul T. Dattani, Jordi Bosch Munoz, Dirk Schnabel, Regis Coutant, Valerie Perrot, Caroline Sert, Cristina Dumitrescu
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ObjectiveThe International Cooperative Growth Study, NutropinAq®European Registry (iNCGS) (NCT00455728) monitored long-term safety and effectiveness of recombinant human growth hormone (rhGH; NutropinAq®[somatropin]) in paediatric growth disorders.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39af22cca372996fd7c19b4a1a66cae
https://www.frontiersin.org/articles/10.3389/fendo.2021.676083/full
https://www.frontiersin.org/articles/10.3389/fendo.2021.676083/full
Autor:
Marcello D. Bronstein, Stephan Petersenn, Aude Houchard, Caroline Sert, Philippe Chanson, Felipe F. Casanueva, Andrea Giustina, Shlomo Melmed
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac5b21147bb9947889bdd2fa483a124b
https://doi.org/10.1530/endoabs.63.p731
https://doi.org/10.1530/endoabs.63.p731
Autor:
Aude Houchard, Marcello D. Bronstein, Stephan Petersenn, Philippe Chanson, Caroline Sert, Felipe F. Casanueva, Shlomo Melmed, Andrea Giustina
Publikováno v:
Pituitary
Purpose The SAGIT® instrument, designed to assist clinicians to stage acromegaly, assess treatment response and adapt patient management, was well received by endocrinologists in a pilot study. We report an interim analysis of baseline data from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1338775acf2ae77d1d0e3ea89361fbeb
Autor:
Charlotte Cookson, Marco Cappa, Caroline Sert, Mehul T. Dattani, Philippe Backeljauw, Lisa Law, Wieland Kiess, John D Whalen
Publikováno v:
Growth Hormone & IGF Research. :101392
Objective We sought to obtain a better understanding of the burden of short stature using a systematic literature review. Methods Studies of the burden of short stature, of any cause in adults and children, were searched using Embase, MEDLINE and Coc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1660fa8912cd4c4a40a839683093f09
https://doi.org/10.1016/j.ghir.2021.101392
https://doi.org/10.1016/j.ghir.2021.101392
Autor:
Fabrice Bonneville, Louis-David Rivière, Stephan Petersenn, John S Bevan, Aude Houchard, Caroline Sert, Philippe J Caron, Gaal L Van, J Marek, P Nuutila, M Välimäki, C Ajzenberg, F Borson-Chazot, T Brue, P Caron, O Chabre, P Chanson, C Cortet Rudelli, B Delemer, J-M Kuhn, A Tabarin, K Badenhoop, C Berg, S Petersenn, C Schöfl, J Schopohl, S Cannavò, A Colao, L De Marinis, A Stades, A J van der Lely, P Kadıoğlu, J S Bevan, D Flanagan, P Trainer
Publikováno v:
European journal of endocrinology.
Objective Pituitary adenoma MRI T2 signal intensity associates with tumor characteristics including responsiveness to somatostatin analogs (SSAs). These analyses determined whether baseline T2 signal intensity predicts response to primary medical tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c4e3e3d1c97523fd4cb61457cff8bc
https://pubmed.ncbi.nlm.nih.gov/30540560
https://pubmed.ncbi.nlm.nih.gov/30540560